Piflufolastat F18 for Breast Cancer
Phase-Based Progress Estimates
Effectiveness
Safety
MD Anderson Cancer Center, Houston, TX
Breast Cancer+7 More
Piflufolastat F18 - DrugEligibility
18+
All Sexes
What conditions do you have?
Select
Eligibility
18+
All Sexes
What conditions do you have?
Select
Study Summary
To learn if piflufolastat F18 can be used in imaging scans for patients with breast cancer, HCC, or pancreatic cancer
Eligible Conditions
- Breast Cancer
- Malignant Neoplasm of Pancreas
- Liver carcinoma
Treatment Effectiveness
Effectiveness Progress
Study Objectives
1 Primary · 0 Secondary · Reporting Duration: through study completion, an average of 1 year
Year 1
Accuracy is defined as the number of concordant cases between PYLARIFY PET-CT and the gold standard truth divided by the total sample size.
Trial Safety
Safety Progress
Trial Design
1 Treatment Group
Piflufolastat F18
1 of 1
Experimental Treatment
36 Total Participants · 1 Treatment Group
Primary Treatment: Piflufolastat F18 · No Placebo Group · Phase < 1
Piflufolastat F18
Drug
Experimental Group · 1 Intervention: Piflufolastat F18 · Intervention Types: DrugTrial Logistics
Trial Timeline
Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: through study completion, an average of 1 year
Closest Location: MD Anderson Cancer Center · Houston, TX
2004First Recorded Clinical Trial
50 TrialsResearching Breast Cancer
521 CompletedClinical Trials
Who is running the clinical trial?
M.D. Anderson Cancer CenterLead Sponsor
2,772 Previous Clinical Trials
1,795,176 Total Patients Enrolled
134 Trials studying Breast Cancer
28,169 Patients Enrolled for Breast Cancer
Lantheus Medical ImagingIndustry Sponsor
50 Previous Clinical Trials
4,331,847 Total Patients Enrolled
2 Trials studying Breast Cancer
228 Patients Enrolled for Breast Cancer
Yang Lu, MD, PHDPrincipal InvestigatorM.D. Anderson Cancer Center
Eligibility Criteria
Age 18+ · All Participants · 10 Total Inclusion Criteria
Mark “yes” if the following statements are true for you:You have at least one lesion on a CT, MRI, or FDG PET-CT.
You have a disease that can be measured by x-ray or CT scan, MRI, or calipers.
You have an estimated life expectancy of at least 3 months.
About The Reviewer
Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.
Top Oncology Trials
Top Clinical Trials in Cities
Relevant Clinical Trials
Unbiased Results
We believe in providing patients with all the options.Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.Back to top
Conditions
Cancer Related
Treatments